RNU6ATAC14P

Across TCGA pan-cancer cohorts, RNU6ATAC14P RNA differs between tumor and matched normal tissue in 7 of 18 cancer types tested, making tumor–normal expression one of RNU6ATAC14P’s most consistent transcriptional readouts.

The strongest signal is observed in breast invasive carcinoma (BRCA), where RNU6ATAC14P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RNU6ATAC14P is over-expressed in tumor, although a few such as KICH and UCEC show the opposite, repressed pattern.

BRCA, KICH, and KIRC are the cancer types where RNU6ATAC14P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RNU6ATAC14P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BRCA	All	III,IV	+1.093	<.001	8	view →
KICH	Male	All	−0.837	<.001	6	view →
KIRC	Male	All	+0.275	.026	3	view →
UCEC	All	All	−0.296	.036	2	view →
LUAD	All	All	+0.136	.027	2	view →
PRAD	All	All	−0.113	.046	2	view →
LUSC	Female	All	+0.265	.039	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 7 strongest of 7 lineages.

RNU6ATAC14P–BRCA

Open the BRCA breakdown →